In a cell-free system of Escherichia coli, RNA from influenza virus particles is translated into a polypeptide antigenically identical with the ribonucleoprotein and several more proteins, some of which correspond in size to viral structural components.
tion of complementary RNA strands, which serve as template for progeny RNA synthesis. These reactions are catalyzed by the virus-specified RNA polymerase that is part of the virion (3) (4) (5) (6) . However, it is unknown whether the RNA from virus particles or their complementary strands serve as messenger for synthesis of virus-specific proteins. Studies on the nature of polysomal RNA from infected cells led to controversial results. Plus strands as well as minus strands have been detected in preparations of polysomes (7) (8) (9) .
A direct approach to solving this question is provided by using RNA from influenza virus particles in an in vitro proteinsynthesizing system and by studying its potential to code for virus-specific proteins.
Recently we demonstrated that RNA from avian myeloblastosis virus is translated with high fidelity in a cell-free system of Escherichia coli (10) . There is additional evidence that the same is true for RNA of Rauscher murine leukemia virus (ref. 11; W. Siegert, unpublished results), mouse mammary tumor virus (11) , and feline leukemia virus (W. Siegert, unpublished results).
We have presented preliminary data suggesting that influenza virus RNA has messenger properties in the E. coli system (12) . Here we wish to present clear evidence that influenza virus particles contain a messenger-like RNA (plus strand) which can be expressed in the E. coli system.
MATERIALS AND METHODS
Influenza virus, fowl plague "Rostock" strain, which was used for pilot experiments, was a gift from Dr. R. Rott, University of Giessen. The experiments reported here were performed with strain A PR8, which was a gift from Dr. R. Siegert, University of Marburg and Dr. H. Bachmayer, SandozForschung, Vienna. Virus was purified from the allantoic fluid of eggs by a sequence of alternating low-and embryonated high-speed centrifugations followed by two isopycnic sucrose gradients (13) . Rauscher leukemia virus and avian myeloblastosis virus were kindly provided by Drs. O'Connor (NIH, Bethesda, Md.) and J. F. Beard (Duke University).
Viral RNA was extracted twice with phenol after digestion with Pronase in the presence of sodium dodecyl sulfate, precipitated twice with ethanol, dissolved in 0.1 M Tris * HCl (pH 7.8) and used for in vitro synthesis (10) . Preparation of the in vitro system, incubation conditions, and analysis of the products on polyacrylamide gels have been described (10, 14, 15 (Fig. 1) .
Synthesis of trichloroacetic acid-precipitable polypeptides continues linearly for about 10 min and then levels off (Fig. 2) .
Characterization of the In Vitro Product by Gel Electrophoresis. To determine if virus-specific proteins were synthesized, the in vitro product was analyzed on sodium dodecyl sulfate-polyacrylamide gels. The radioactivity pattern of the in vitro proteins was compared with that of proteins of the 10 -ul aliquots were dried on paper filter disks and processed for detection of radioactivity, as described in the legend to Table 1. influenza virion (Fig. 3 ). and were run at 2.5) mA per gel at room temperature until the dye marker reached the bottom of the tube. The gels loaded with virus proteins were stained with Coomassie blue and scanned at 630 nm in a Gilford spectrophotometer. For determination of radioactivity, the gels were sliced and disolved in hydrogen peroxide and Protosol Solubilizer (New England Nuclear). P indicates slowly migrating polypeptide; NP, nucleoprotein; HA1 and HA2, hemagglutinin subunits; NA, neuraminidase; M, membrane protein.
demonstrates that influenza virus RNA directs the in vitro synthesis of high-molecular-weight proteins, most of which correspond in size to individual viral proteins. The nature of polypeptides that do not correspond in size to virion proteins, especially the material in fractions 40 and 41 and 65-80, will be discussed later.
Analysis of the In Vitro Product by Immunodiffusion. The fact that influenza virus RNA codes for synthesis of proteins that correspond in size to the proteins present in the virion supports the concept that the RNA is translated correctly. To obtain further evidence for the identity of the in vitro proteins with virion proteins, we tested whether among the synthesized proteins there is one that has the antigenic properties of ribonucleoprotein A. Influenza in vitro proteins labeled with [35S]methionine were mixed with unlabeled influenza virions as carrier and allowed to diffuse toward various antisera to viral proteins (Fig. 4) . Among the precipitation lines detected, there is one that contains ribonucleoprotein A antigen (Fig. 4a) , and it is obvious from the autoradiogram (Fig. 4b) that radioactive material is coprecipitated with unlabeled virion antigen. Precipitation lines corresponding to the hemagglutinin and the neuraminidase (16) are not clearly separated, but also contain radioactivity. the immunoprecipitates. In the experiment shown in Fig. 4c 
